SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Gennex Laboratories to raise funds through permissible modes

29 Mar 2022 Evaluate

Gennex Laboratories is planning to raise funds by issuance of equity shares or any other securities, through permissible modes including but not limited to a rights issue, as may be permitted under applicable law and subject to such regulatory/ statutory approvals, as may be required. A meeting of Board of Directors of the Company will be held on April 06, 2022 to consider the same.

Gennex Laboratories is engaged in the manufacture and export of bulk drugs and intermediates. The product range of the company includes Guaiphenesin,Methocarbamol,Fluconazole and Phenazopyridine. 

Gennex Lab Share Price

10.41 0.11 (1.07%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×